05/05/2026
World Asthma Day 2026 is here.
The Global Initiative for Asthma has set this year's theme as "Access to anti-inflammatory inhalers for everyone with asthma – still an urgent need."
The numbers tell a sobering story: • 260+ million people live with asthma worldwide • 450,000+ deaths each year, most of them preventable • 96% of asthma deaths occur in low- and middle-income countries.
Inhaled corticosteroids are essential. They treat the airway inflammation that drives asthma, prevent attacks, and save lives. But cost and availability still keep these medicines out of reach for too many people.
At Allergy Standards, we believe better asthma outcomes require both equitable access to medication and healthier indoor environments. Through the AAFA's asthma & allergy friendly Certification Program run with the Asthma and Allergy Foundation of America (AAFA), we test and certify products that reduce exposure to common indoor triggers including dust mite allergen, pet dander, mold, and VOCs.
Today, we join GINA and advocates around the world in calling for action. Everyone with asthma deserves the medication and the environments they need to thrive. Read our blog: https://www.allergystandards.com/news_events/world-asthma-day-2026-closing-the-global-gap-in-asthma-care/
World Asthma Day 2026, May 5: "Access to anti-inflammatory inhalers for everyone with asthma – still an urgent need." Image courtesy of the Global Initiative for Asthma (GINA).